Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Comparison of 5 BMPs for their chondrogenic potentials and microfracture-mediated cartilage repair using heparin/PEAD coacervate sustained release polymer

Gao X., Wright N., Huard M., Tan J., Ruzbarsky J., Lu A.

Animal Study on Osteoarthritis, Cartilage Damage, published in Bioact Mater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Bioact Mater (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40607117
PMCID
PMC12219002
DOI
10.1016/j.bioactmat.2025.06.031

Abstract (original English)

Cartilage defect repair and osteoarthritis treatments remain clinical challenges. Microfracture is a commonly used surgical procedure for the treatment of cartilage defects but often leads to fibrocartilage repair. The aim of this study is to compare the effects of 5 bone morphogenetic proteins (BMPs) on chondrogenic differentiation of human bone marrow mesenchymal stem cells, as well as to investigate the use of the heparin/poly (ethylene arginine aspartate diglyceride (PEAD) coacervate sustained release system to deliver these BMPs for microfracture-mediated cartilage repair. Our results indicate that all 5 human BMPs significantly enhance the chondrogenic differentiation of human bone marrow mesenchymal stem cells (hBMMSCs) with BMPs 2,4 and 9 being more potent than BMP6 or BMP7, as revealed by Alcian blue, SO staining, and immunohistochemistry of COL2. Coacervate-BMPs are biocompatible for both hBMMSCs and rat muscle-derived stem cells (MDSCs) and promote their proliferation. In vivo , sustained release of human BMPs 2,4,6,7,9 with heparin/PEAD coacervate significantly enhances microfracture-mediated cartilage repair in a rat osteochondral defect model, as demonstrated by ICRS macroscopic score, Seller's histology score, and COL2 staining. These effects are mediated by increasing SOX9 expression in the regenerated cartilage. In conclusion, BMPs 2,4,9 are the most potent BMP

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research